Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
115M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
+993K
-
Total reported value, excl. options
-
$291M
-
Value change
-
+$15.6M
-
Number of buys
-
44
-
Number of sells
-
-33
-
Price
-
$20.04
Significant Holders of Coherus Oncology, Inc. - Common Stock (CHRS) as of Q3 2015
90 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock as of Q3 2015.
Coherus Oncology, Inc. - Common Stock (CHRS) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 115M outstanding shares and own 12.58% of the company stock.
Largest 10 shareholders include FMR LLC (3.75M shares), JPMORGAN CHASE & CO (1.37M shares), VHCP Management, LLC (870K shares), Tourbillon Capital Partners, L.P. (784K shares), TIAA CREF INVESTMENT MANAGEMENT LLC (758K shares), BlackRock Fund Advisors (618K shares), VANGUARD GROUP INC (597K shares), Cormorant Asset Management, LLC (569K shares), FEDERATED INVESTORS INC /PA/ (410K shares), and BlackRock Institutional Trust Company, N.A. (375K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.